Telomeres, lifestyle, cancer, and aging

Purpose of reviewThere has been growing evidence that lifestyle factors may affect the health and lifespan of an individual by affecting telomere length. The purpose of this review was to highlight the importance of telomeres in human health and aging and to summarize possible lifestyle factors that may affect health and longevity by altering the rate of telomere shortening. Recent findingsRecent studies indicate that telomere length, which can be affected by various lifestyle factors, can affect the pace of aging and onset of age-associated diseases. SummaryTelomere length shortens with age. Progressive shortening of telomeres leads to senescence, apoptosis, or oncogenic transformation of somatic cells, affecting the health and lifespan of an individual. Shorter telomeres have been associated with increased incidence of diseases and poor survival. The rate of telomere shortening can be either increased or decreased by specific lifestyle factors. Better choice of diet and activities has great potential to reduce the rate of telomere shortening or at least prevent excessive telomere attrition, leading to delayed onset of age-associated diseases and increased lifespan. This review highlights the role of telomeres in aging and describes the lifestyle factors which may affect telomeres, human health, and aging.

[1]  M. Babizhayev,et al.  Telomere Length is a Biomarker of Cumulative Oxidative Stress, Biologic Age, and an Independent Predictor of Survival and Therapeutic Treatment Requirement Associated With Smoking Behavior , 2011, American journal of therapeutics.

[2]  H. Kestler,et al.  Lifestyle impacts on the aging‐associated expression of biomarkers of DNA damage and telomere dysfunction in human blood , 2010, Aging cell.

[3]  Yan Liu,et al.  Associations between diet, lifestyle factors, and telomere length in women. , 2010, The American journal of clinical nutrition.

[4]  A. Baccarelli,et al.  Shorter telomere length in peripheral blood lymphocytes of workers exposed to polycyclic aromatic hydrocarbons. , 2010, Carcinogenesis.

[5]  Mary A Whooley,et al.  Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease. , 2010, JAMA.

[6]  Thomas Widmann,et al.  Physical Exercise Prevents Cellular Senescence in Circulating Leukocytes and in the Vessel Wall , 2009, Circulation.

[7]  J. Schwartz,et al.  Association between leukocyte telomere shortening and exposure to traffic pollution: a cross-sectional study on traffic officers and indoor office workers , 2009, Environmental health : a global access science source.

[8]  P. Ridker,et al.  Association of shorter mean telomere length with risk of incident myocardial infarction: a prospective, nested case-control approach. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[9]  A. Neugut,et al.  Telomere length, oxidative damage, antioxidants and breast cancer risk , 2009, International journal of cancer.

[10]  L. Rudolph,et al.  Short Telomeres and Prognosis of Hypertension in a Chinese Population , 2009, Hypertension.

[11]  N. Munshi,et al.  Dysfunctional homologous recombination mediates genomic instability and progression in myeloma. , 2009, Blood.

[12]  O. Melander,et al.  Telomere Length Is Associated With Obesity Parameters but With a Gender Difference , 2008, Obesity.

[13]  M. Manns,et al.  Proteins induced by telomere dysfunction and DNA damage represent biomarkers of human aging and disease , 2008, Proceedings of the National Academy of Sciences.

[14]  K. Anderson,et al.  Telomere Maintenance in Laser Capture Microdissection–Purified Barrett's Adenocarcinoma Cells and Effect of Telomerase Inhibition In vivo , 2008, Clinical Cancer Research.

[15]  R. Cawthon,et al.  Prognostic Value of Leukocyte Telomere Length in Patients With Stable Coronary Artery Disease: Data From the Heart and Soul Study , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[16]  A. Protopopov,et al.  Telomerase inhibitor GRN163L inhibits myeloma cell growth in vitro and in vivo , 2008, Leukemia.

[17]  T. Spector,et al.  The association between physical activity in leisure time and leukocyte telomere length. , 2008, Archives of internal medicine.

[18]  D. Hunter,et al.  Telomere Length, Cigarette Smoking, and Bladder Cancer Risk in Men and Women , 2007, Cancer Epidemiology Biomarkers & Prevention.

[19]  A. Aviv,et al.  Telomere length in leukocytes correlates with bone mineral density and is shorter in women with osteoporosis , 2007, Osteoporosis International.

[20]  Jean Adams,et al.  No association between socio‐economic status and white blood cell telomere length , 2007, Aging cell.

[21]  M. Blasco,et al.  Telomere length regulates the epigenetic status of mammalian telomeres and subtelomeres , 2007, Nature Genetics.

[22]  N. Samani,et al.  Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study , 2007, The Lancet.

[23]  R. Kronmal,et al.  Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. , 2006, American journal of epidemiology.

[24]  A. Hall,et al.  Telomere length of circulating leukocytes is decreased in patients with chronic heart failure. , 2006, Journal of the American College of Cardiology.

[25]  X. Busquets,et al.  Telomere shortening in smokers with and without COPD. , 2006, The European respiratory journal.

[26]  A. Hong,et al.  The role of telomeres and telomerase in the pathology of human cancer and aging , 2006, Pathology.

[27]  A. Meeker,et al.  Telomeres and telomerase in prostatic intraepithelial neoplasia and prostate cancer biology. , 2006, Urologic oncology.

[28]  M. Sampson,et al.  Monocyte telomere shortening and oxidative DNA damage in type 2 diabetes. , 2006, Diabetes care.

[29]  M. Esteller.  Epigenetics provides a new generation of oncogenes and tumour-suppressor genes. , 2006, British journal of cancer.

[30]  M. Blasco,et al.  XPF nuclease-dependent telomere loss and increased DNA damage in mice overexpressing TRF2 result in premature aging and cancer , 2005, Nature Genetics.

[31]  A. Aviv,et al.  Obesity, cigarette smoking, and telomere length in women , 2005, The Lancet.

[32]  A. Protopopov,et al.  Telomerase inhibition by siRNA causes senescence and apoptosis in Barrett's adenocarcinoma cells: mechanism and therapeutic potential , 2005, Molecular Cancer.

[33]  T. Lange,et al.  DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion , 2005, Nature Cell Biology.

[34]  T. de Lange.  Telomere-related genome instability in cancer. , 2005, Cold Spring Harbor symposia on quantitative biology.

[35]  T. Lange.  Telomere-related genome instability in cancer. , 2005 .

[36]  Morihiro Matsuda,et al.  Increased oxidative stress in obesity and its impact on metabolic syndrome. , 2004, The Journal of clinical investigation.

[37]  E. Epel,et al.  Accelerated telomere shortening in response to life stress. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[38]  N. Munshi,et al.  Telomerase Inhibition, Telomere Shortening and Apoptotic Cell Death in Multiple Myeloma Cells Following Exposure to a Novel and Potent Telomerase Inhibitor (GRN163L), Targeting RNA component of Telomerase. , 2004 .

[39]  J. Shay,et al.  Modification of Subtelomeric DNA , 2004, Molecular and Cellular Biology.

[40]  D. Beer,et al.  Growth arrest, apoptosis, and telomere shortening of Barrett's-associated adenocarcinoma cells by a telomerase inhibitor. , 2004, Gastroenterology.

[41]  Shankar Balasubramanian,et al.  Targeting the single-strand G-rich overhang of telomeres with PNA inhibits cell growth and induces apoptosis of human immortal cells. , 2004, Experimental cell research.

[42]  J. Staessen,et al.  Telomere length and possible link to X chromosome , 2004, The Lancet.

[43]  N. Munshi,et al.  Telomerase Inhibition and Cell Growth Arrest After Telomestatin Treatment in Multiple Myeloma , 2004, Clinical Cancer Research.

[44]  B. Pützer,et al.  p73 in apoptosis , 2001, Apoptosis.

[45]  H. Kasai,et al.  Depressive state relates to female oxidative DNA damage via neutrophil activation. , 2003, Biochemical and biophysical research communications.

[46]  N. Munshi,et al.  Effects of oligonucleotide N3'-->P5' thio-phosphoramidate (GRN163) targeting telomerase RNA in human multiple myeloma cells. , 2003, Cancer research.

[47]  K. Anderson,et al.  Telomerase inhibition and cell growth arrest by G-quadruplex interactive agent in multiple myeloma. , 2003, Molecular cancer therapeutics.

[48]  M. Spitz,et al.  Telomere dysfunction: a potential cancer predisposition factor. , 2003, Journal of the National Cancer Institute.

[49]  N. Samani,et al.  White Cell Telomere Length and Risk of Premature Myocardial Infarction , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[50]  R. Cawthon,et al.  Association between telomere length in blood and mortality in people aged 60 years or older , 2003, The Lancet.

[51]  S. Brooke,et al.  Disruptive effects of glucocorticoids on glutathione peroxidase biochemistry in hippocampal cultures , 2002, Journal of neurochemistry.

[52]  T. Zglinicki.  Oxidative stress shortens telomeres , 2002 .

[53]  T. von Zglinicki.  Oxidative stress shortens telomeres. , 2002, Trends in biochemical sciences.

[54]  T. Vulliamy,et al.  The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita , 2001, Nature.

[55]  R. Reddel,et al.  Telomere maintenance by recombination in human cells , 2000, Nature Genetics.

[56]  M. Oshimura,et al.  Telomere shortening with aging in human liver. , 2000, The journals of gerontology. Series A, Biological sciences and medical sciences.

[57]  B. J. Jennings,et al.  Nutrition, oxidative damage, telomere shortening, and cellular senescence: individual or connected agents of aging? , 2000, Molecular genetics and metabolism.

[58]  D. Corey,et al.  Telomerase inhibition by peptide nucleic acids reverses `immortality' of transformed human cells , 1999, Oncogene.

[59]  Antonio Costanzo,et al.  The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage , 1999, Nature.

[60]  J. Griffith,et al.  Mammalian Telomeres End in a Large Duplex Loop , 1999, Cell.

[61]  Lynda Chin,et al.  p53 Deficiency Rescues the Adverse Effects of Telomere Loss and Cooperates with Telomere Dysfunction to Accelerate Carcinogenesis , 1999, Cell.

[62]  B. J. Jennings,et al.  Early growth determines longevity in male rats and may be related to telomere shortening in the kidney , 1999, FEBS letters.

[63]  E. Blackburn,et al.  The rate of telomere sequence loss in human leukocytes varies with age. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[64]  Bas van Steensel,et al.  TRF2 Protects Human Telomeres from End-to-End Fusions , 1998, Cell.

[65]  C. Harley,et al.  Extension of life-span by introduction of telomerase into normal human cells. , 1998, Science.